Abstract
For the first time, biologics have been recommended for the treatment of moderate rheumatoid arthritis (RA) in final draft guidance from the National Institute for Health and Care Excellence (NICE). The guidance, which was published on 10 June 2021, says that adalimumab, etanercept and infliximab, all taken with methotrexate, are recommended for use within the […]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
